Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocol

Background: While precision medicines targeting genetic mutations and alterations in non-small cell lung cancer (NSCLC) have been available since 2010, their adoption into clinical practice has been slow. Evidence suggests that a number of barriers, such as insufficient clinician knowledge, a need f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Stuart, Daker-White, Gavin, Newman, William, Payne, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934686/
https://www.ncbi.nlm.nih.gov/pubmed/29780892
http://dx.doi.org/10.12688/wellcomeopenres.13976.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934686/
https://www.ncbi.nlm.nih.gov/pubmed/29780892
http://dx.doi.org/10.12688/wellcomeopenres.13976.1

Ejemplares similares